General
Rossari Biotech Ltd posts net profit of Rs.25.68 crores in Q3 FY23
The company has reported total income of Rs.390.383 crores during the period ended December 31, 2022 as compared to Rs.433.771 crores during the period ended December 31, 2021
- By ICN Bureau
| February 06, 2023
Rossari Biotech Ltd has reported total income of Rs. 390.383 crores during the period ended December 31, 2022 as compared to Rs. 426.256 crores during the period ended September 30, 2022.
The company has posted net profit of Rs. 25.681 crores for the period ended December 31, 2022 as against net profit of Rs. 23.916 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 4.63 for the period ended December 31, 2022 as compared to Rs. 4.32 for the period ended September 30, 2022.
The company has reported total income of Rs.390.383 crores during the period ended December 31, 2022 as compared to Rs.433.771 crores during the period ended December 31, 2021.
The company has posted net profit of Rs.25.681 crores for the period ended December 31, 2022 as against net profit of Rs.22.539 crores for the period ended December 31, 2021.
The company has reported total income of Rs.1252.093 crores during the 9 Months period ended December 31, 2022 as compared to Rs.1054.066 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit of Rs.78.278 crores for the 9 Months period ended December 31, 2022 as against net profit of Rs.73.290 crores for the 9 Months period ended December 31, 2021.
Register Now to Attend Gujarat Chem & Petchem Conference 2025 on May 8-9th 2025, at Hyatt Place, Bharuch
Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2025 on June 18-19th 2025, The Leela Mumbai
